Skip to content
Cystic Fibrosis News Today logo Newsletter
Newsletter
  • About CF
    What is cystic fibrosis?
    • Symptoms
    • Diagnosis
    • Causes and inheritance
    • Types of CFTR mutations
    Treatment
    • Approved treatments
    • Experimental treatments
    • Non-drug treatments
  • Living with
    Living with CF
    Heat and humidity tips
    Upper and lower respiratory tract infections
    Tips for preventing reflux
  • News
  • Community
    Columns
    • Air of Life — Ed Jordan
    • Living Beyond – Jennifer Cogliano
    • Valiant Voice — Lara Govendo
    • Victorious — Brad Dell
    • Mutations & Conversations — Tré LaRosa
    Archived columns
    • Advocacy and Abnormality — Kristin Entler
    • Understanding Nonsense — William Ryan
    Videos
    • CF love story
    • CF travel tips
    • Shaping change in the CF community
    • Talking about struggles
    Features
    • Rediscovery
    • CF Vests Worldwide
  • Forums
  • CF Spotlight
  • What can we help you find today?

  • Social Clips
  • Everything You Need to Know About Orkambi

Everything You Need to Know About Orkambi

admin avatar

by admin | October 2, 2015

Share this article:

Share article via email

news-12

Orkambi is a combination therapy for treatment of cystic fibrosis. The FDA approval for the therapy was announced on July 2nd, 2015.

Learn all about it here: https://bit.ly/1jCoQUT

Print This Page

Tags

Orkambi

Your CF Community


Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.

Recent Posts

  • The importance of food safety for a transplant recipient with CF December 5, 2025
  • Life expectancy is a useful metric, but it doesn’t tell the whole story December 4, 2025
  • Finding comfort in routine after a heartbreaking CF diagnosis December 3, 2025
  • Panel recommends revised dosing for trial of CF treatment BX004 December 2, 2025
  • Understanding physiological effects of anxiety and chronic illness November 28, 2025


Recommended reading

banner for Tre LaRosa's column
December 4, 2025 Columns by Tré LaRosa

Life expectancy is a useful metric, but it doesn’t tell the whole story

December 3, 2025 Columns by Ed Jordan

Finding comfort in routine after a heartbreaking CF diagnosis

A person in a baseball cap speaks through a megaphone.
December 2, 2025 News by Andrea Lobo, PhD

Panel recommends revised dosing for trial of CF treatment BX004

Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

This field is for validation purposes and should be left unchanged.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.